http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020091641-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7b9ae4d7cd0f6e34bca050872bbef98 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 |
| filingDate | 2001-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35b546f813da0eed0b1c07127987c13 |
| publicationDate | 2002-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20020091641-A |
| titleOfInvention | Pharmaceutical composition comprising a swellfish extract for anticancer therapy |
| abstract | The present invention relates to a pharmaceutical composition containing a blowfish extract, and more particularly to a pharmaceutical composition that can treat various cancers, such as breast cancer, stomach cancer, lung cancer, liver cancer, ovarian cancer using the aqueous extract of pufferfish eggs.n n n The present invention is an anticancer pharmaceutical composition containing a puffer fish extract as an active ingredient and a pharmaceutically acceptable additive, wherein the active ingredient is 5-fluorouracil, methotrexate, adriamycin, known as an anticancer agent in addition to the puffer fish extract. It may further contain one or more anticancer agents selected from the group consisting of Taxol. The puffer fish extract was taken from a puffer fish, and 1 kg of eggs were taken. Then, 3 liters of water were put in, and the extract was heated and heated at about 100 ° C. for 24 hours, followed by centrifugation in a conventional manner to remove suspended solids. Is prepared.n n n Therefore, the puffer fish extract of the present invention can obtain an anticancer effect when administered to a cancer patient and can also control the pain of the cancer patient, so as to not only the anticancer treatment effect when administered to a cancer patient complaining of pain, but also an analgesic effect. It has the advantages obtained together. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100537437-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006004377-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100495173-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018222-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007110221-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10624896-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2394646-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100603942-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200084704-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419873-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149852-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040000037-A |
| priorityDate | 2001-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.